CB
50
-5
FLR
48
5
LUV
65
2
CI
45
-3
RHI
32
-2
NWS
90
2
VLO
43
-3
JWN
69
-4
HRB
88
3
EL
52
-4
TAP
38
-3
PNC
48
-4
L
58
-6
AA
53
2
CMA
46
-4
O
42
-4
GS
76
6
AIG
60
-6
JNJ
29
-3
MAR
50
2
CB
50
-5
FLR
48
5
LUV
65
2
CI
45
-3
RHI
32
-2
NWS
90
2
VLO
43
-3
JWN
69
-4
HRB
88
3
EL
52
-4
TAP
38
-3
PNC
48
-4
L
58
-6
AA
53
2
CMA
46
-4
O
42
-4
GS
76
6
AIG
60
-6
JNJ
29
-3
MAR
50
2
Financhill
Back

Intra-Cellular Therapies Vs. Fate Therapeutics Industry Stock Comparison

Sell
38

ITCI
Intra-Cellular Therapies

Last Price:
66.97
Seasonality Move:
-6.93%
Buy
51

FATE
Fate Therapeutics

Last Price:
3.69
Seasonality Move:
9.33%
Sell
38
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $65.32. The Score for ITCI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Fate Therapeutics (FATE) is a Buy

Is Fate Therapeutics a Buy, Sell or Hold?

  • The current Fate Therapeutics [FATE] share price is $3.91. The Score for FATE is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • FATE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $65.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight buying pressure.

FATE Stock Price Chart

What is Fate Therapeutics's stock price today?

  • The Fate Therapeutics share price today is $3.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing slight buying pressure.

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.32 Sell
Relative Strength Index (14 RSI): 41.48 Sell
Chaikin Money Flow: 421582 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.45 - 74.29) Sell
Bollinger Bands (100): (65.99 - 72.19) Sell

FATE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.41 Sell
Relative Strength Index (14 RSI): 34.58 Sell
Chaikin Money Flow: 93703 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.81 - 4.71) Sell
Bollinger Bands (100): (4.25 - 7.09) Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.78 Sell
20-day SMA: 69.19 Sell
50-day SMA: 68.67 Sell
200-day SMA: 62.8 Buy
8-day EMA: 66.34 Sell
20-day EMA: 68 Sell
50-day EMA: 68.71 Sell
200-day EMA: 64.66 Buy

FATE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.07 Sell
20-day SMA: 4.06 Sell
50-day SMA: 5.6 Sell
200-day SMA: 4.05 Sell
8-day EMA: 4.04 Sell
20-day EMA: 4.31 Sell
50-day EMA: 5.03 Sell
200-day EMA: 5.51 Sell

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.10 per share, and an increase next year of $1.43 per share.

Fate Therapeutics Earnings Growth & FATE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.13 per share, and an increase next year of $0.07 per share.

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Fate Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):